SCHEMBL19913207

SCHEMBL19913207

Cc1cc(C)c(-c2ccc3c4ccc(-c5c(C)cc(C)cc5C)cc4n(-c4cc(C#N)c(-c5ccncc5)cc4-n4c5cc(-c6c(C)cc(C)cc6C)ccc5c5ccc(-c6c(C)cc(C)cc6C)cc54)c3c2)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.37
PDE3B Q13370 4/20 0.37
PDE3A Q14432 4/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PDE5A O76074 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
PTGS1 P23219 1/20 0.37
PDE4A P27815 1/20 0.37
CYP2C19 P33261 1/20 0.37
BLM P54132 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
METAP2 P50579 1/20 0.35
ABL1 P00519 1/20 0.34
CFTR P13569 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919628 0.95 SQOR (0.34) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19913114 0.92 PDE3B (0.36) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19919774 0.92 PDE3B (0.38) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19919627 0.89 SQOR (0.35) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19919631 0.89 PDE3B (0.38) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19913121 0.89 SQOR (0.34) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL22019746 0.88 MEN1 (0.39) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19913214 0.88 ALDH1A1 (0.31) KDM4ETSHR
SCHEMBL19919761 0.87 LMNA (0.39) XDHPDE3BPDE3ALMNAKDM4E
SCHEMBL19909264 0.86 PDE3B (0.41) XDHPDE3BPDE3ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 XDH 483/4885PDE3B 1366/4885PDE3A 1793/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 XDH 483/4885PDE3B 1366/4885PDE3A 1793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.